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1. Introduction the current evidence which suggests a situation that 
is more complex than that envisaged in [7]. 
The human rheumatic and connective tissue dis- 
eases are a group of conditions which display auto- 
immune properties, many of the serum antibody activ- 
ities being directed against components of the cell 
nucleus [I ,2]. Although antibodies to DNA are char- 
acteristic of these conditions, it is of clinical impor- 
tance that activities against the so-called soluble 
nuclear protein-containing antigens have been found 
to act as markers for specific diseases [ 1,2]. The 
demonstration [3-61 that several of these nuclear 
antigens are ribonucleoprotein particles containing 
small nuclear RNA species (snRNA) has also led to an 
interest in the use of their specific antibodies due to 
the proposal that snRNAs may be involved in mecha- 
nisms for ‘splicing’ mRNA precursors in the cell 
nucleus [4,5,7]. 
2. Analysis of Sm and RNP antigens as RNA-protein 
complexes 
Details of the reports of the composition of Sm 
and RNP antigens are summarised in table 1. Analyses 
have been carried out on antigens obtained by proce- 
dures which range from various forms of preparative 
immunoaffinity chromatography to the precipitation 
of immune complexes using Staphylococcus protein 
A. Our own approach as been to form immunopre- 
cipitates under conditions of equivalence for each 
antigen, followed by analysis of their protein and 
RNA contents by polyacrylamide gel electrophoresis. 
2.1. Sm 
Specifically,Lerneretal.([3,4,6,8,10],reviewedin Table 1 shows that several laboratories have been 
[7]) have investigated the composition of the nuclear able to confirm that the proteins associated with this 
antigens known as Sm, RNP and La (or Ha), anti- antigen are within M, 12 000-14 000, but exceptions 
bodies to which are characteristic of systemic lupus of qualitative [ 17-191 and quantitative natures exist, 
erythematosus, mixed connective tissue disease and e.g., the lower M, polypeptides are common to most 
Sjogren’s syndrome, respectively. These workers found studies but they are reported as representing either 
that immune complexes containing Sm or RNP anti- minor [4] or major [13,19] components. By analysing 
gens which had been prepared in vitro possessed the specific immunoprecipitates wehave found that the 
same set of seven proteins (M, 12 000-35 000), but 
differing types of snRNAs, viz. U,,,,,,&Sm) and 
major proteins associated with Sm are ofM, - 10 000 
(4 components) and -12 000 (1 component) [9]. 
Ur(RNP). La antigen was found to be associated Several authors have reported the presence of a pro- 
with a heterogeneous group of small RNAs, including 
several coded by infecting DNA viruses [6,8]. How- 
tein of M, 26 000 in Sm (and RNP) but this would 
not be seen in the presence of IgG light chains in 
ever, several other laboratories have found the com- SDS-polyacrylamide gels [9]. Although there is not 
position of the Sm and RNP antigens to differ signif- complete qualitative agreement amongst the investi- 
icantly from those in [3,7] (see [9]). We review here gations of Sm, components similar to the 5 proteins 
Published by Elsevier Biomedical Press 
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above have been reported by others, including Lemer 
and Steitz [4], provided allowance is made for differ- 
ences in estimates of M,-value. 
However, the greatest discrepancy in analysis con- 
cerns the RNA content of Sm since various combina- 
tions of known and unidentified small RNA species 
have been reported (table 1). Our own results show 
that Sm antigen from pig thymus is associated with 
some 10 small RNAs migrating in polyacrylamide gel 
electrophoresis between 4 S and 5 S RNA [9]. Of the 
other laboratories which have also found similar spe- 
cies, two have used thymus as a source of antigen 
[18,19,21]. 
2.2. RNP 
As indicated in table 1, a general qualitative simi- 
larity has been found amongst the analysis of the pro- 
teins of RNP antigens prepared in various laboratories 
and with those of Sm antigen. The striking exception 
to this overall view is the difference in analyses of 
HeLa RNP found in [4,12]. Using preparations and 
procedures apparently identical to those in [4], the 
latter group identified 5 proteins (M, 45 000-60 000) 
as being associated with RNP antigen (although signif- 
icant amounts of proteins with iV2, > 60 000 and 
<40 000, including a 10 000 Mr group, were also 
present). The low M, group (10 000-l 2 000) is com- 
mon to most studies and in some cases [ 191 the RNP 
antigen is reported to have at least one extra polypep- 
tide. The latter aspect is confirmed in our own inves- 
tigations in which we found the RNP antigen of pig 
thymus to be associated with a protein of il4r 30 000 
which was not found in similar analysis of Sm antigen 
[9]. Where qualitative differences have been reported, 
these tend to refer to highMr proteins (cf. [4] and 
[12,18-201). 
Lerner et al. [3,4,6,7] and Lenk et al. [ 121 have 
shown that RNP antigen from several cell sources 
contains only U, as the dominant snRNA species, yet 
other laboratories find that in their preparations either 
the U, is accompanied by identified plus unidentified 
snRNAs [ 131 or the RNA consists only of very small 
species [9,18,19]. As in the case of Sm, it is significant 
that the very small RNA molecules are obtained when 
RNP is prepared from thymus nuclei [9,18,19,21]. 
However, it should be noted that extended exposure 
of autoradiograms of RNA gels containing RNP- 
immunoprecipitates showed the presence of at least 
2 additional small RNA components with mobilities 
between 4 Sand 5 S RNA [12]. 
2.3. Further investigations 
In view of the apparent discrepancies between our 
results [9] and those of others listed in table 1, we 
have carried out the following checks (A. R. C., 
M. R. S., unpublished): 
(1) We were able to show that, relative to those of 
rat liver nuclei, the snRNAs of pig thymus differed 
both quantitatively and qualitatively, U, and 
only trace amounts of the other species being 
present; 
(2) Saline extracts containing Sm/RNP from rat liver 
nuclei showed Ur as the dominant snRNA but 
this was not the case in similar preparations from 
pig thymus in which UZ was also virtually absent; 
(3) When such liver and thymus extracts were used 
to form immune complexes containing Sm/RNP 
according to [3], a wide range of RNA species 
was observed, that from liver containing U1_-6 
snRNAs as well as large and very small RNAs. 
However, when complexes were formed from 
thymus extracts virtually no traces of known 
snRNAs were seen, the large and very small mole- 
cules predominating. The latter are probably those 
seen in immunoprecipitates of thymus Sm and 
RNP [9], whereas large components of unknown 
identity are a feature of most of the analysis 
quoted in table 1; 
(4) We have found (in collaboration with Dr G. E. 
Blair, University of Leeds) that sera used in [9] 
wiLl yield immune complexes from radioactively 
labelled HeLa cell extracts with compositions 
identical to those found in [7]. 
We conclude that, given the presence of only certain 
of the UsnRNAs in pig thymus, Sm and RNP antigens 
prepared from such cells are not associated with any 
significant amounts of these RNAs. Yet, if HeLa cell 
extracts are used, the same sera will precipitate 
snRNA-protein complexes similar to those reported 
by Lerner and Steitz [7]. 
3. Analysis of Sm and RNP antigens as determinants 
on isolated protein or RNA molecules 
Table 2 summarises the results of investigations in 
which anti-Sm-RNP antibodies have been reacted with 
individual protein or RNA molecules. Two approaches 
have been used: 
(1) Those using ‘blotting’ techniques whereby pro- 
teins from purified antigens are separated by gel 
141 
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Protein and RNA components of Sm and RNP showing antigenic properties 
Antibody Antigen sources Detection method Antigen Ref. 
Protein 
(M, x 10-3) 
RNA 
Human us Sm 
Mouse MC us Sm 
HeLa Protein blot 
Human vs RNP Calf thymus 
Human us RNP 
Human YS Sm 
Human vs RNP 
Human vs Sm 
Mouse MC vs RNP 
Human vs RNP 
Human vs Sm 
Haemagglutination 
Inhibition 
Calf thymus 
Haemagglutination 
Inhibition 
Solid phase RIA 
Solid phase RIA 
Rabbit thymus 
Calf thymus 
Rabbit thymus 
Calf thymus 
Protein blot 
? Protein blot 
Ehrlich Ascites 
cells 
Immune complex 
Precipitation 
26 
26 
(X2) 13 
30,65 
13 
(13), 40, (X 2) 70 
<6.5, 12, 13, (x2) 30 
13 
13, ?30 
40, (X 2) 70 
40,60 nucleosides [I81 
(RNP-RNA -ve) [I91 
[221 
(Rat liver 
nuclear -ve) 
1231 
[ill 
(snRNAs -ve) [31 
Abbreviations: MC, monoclonal; RIA, radioimmunoassay 
electrophoresis prior to transfer to a second 
matrix on which antigens are detected by double 
antibody or similar techniques; 
(2) Those in which RNA or protein is recovered from 
electrophoresis gels and the presence of antigen 
determined by conventional immunoassays. 
Once more there is little overall consistency in the 
results obtained by different laboratories, e.g., anti-Sm 
antibodies are found to react with either a 13 000 M, 
[19,23] or a 26 OOOM, [22] protein. Of the reports 
in which RNA molecules were tested only one [ 181 
showed evidence of reaction with antibody. 
4. Correspondence between Sm and RNP antigens 
Lemer and Steitz [7] view their data as indicating 
that anti-Sm/RNP antibodies recognise determinant 
sites on snRNPparticles, each of the U-series of snRNA 
being complexed with proteins in specific particles. 
Should such a model be correct, then it implies that 
in the cells studied by Lerner and Steitz one snRNP 
142 
particle (UrsnRNP) possesses antigenic sites for both 
Sm and RNP (other snRNPs containing U2 4 5 or 6 
react only with anti-Sm antibodies). Examhat!lon of 
other data in table 1 suggest hat, according to the 
model of Lerner and Steitz, both Sm and RNP deter- 
minants are found together in more than one type of 
snRNP particle in Friend erythroleukaemic and thy- 
mus cells. Previous work has also been interpreted as 
indicating that the antigens are part of the same 
nuclear complex [ 16,241, particularly the claims that 
on purification Sm and RNP can show properties of 
RNP and Sm, respectively [ 19,211. In contrast both 
Jonsson’s laboratory and our own have shown that 
Sm and RNP can be separated by chromatography of 
saline extracts of thymus and lymphocyte nuclei 
([9,25]; M. R. S., unpublished). Such results can be 
interpreted as indicating that either hidden antigenic 
sites remain undisturbed under these conditions or 
the determinants are on separate complexes. The 
recent claims (table 2) that the antigenic sites for Sm 
and RNP have been located on isolated proteins makes 
the latter proposal feasible. As a result of these data 
Volume 141, number 2 FEBS LETTERS May 1982 
and those in tables 1 and 2 we feel that models other 
than that in [7] should be considered and this aspect 
will be given further consideration below. 
5. Factors influencing antigen composition 
The true identity of nuclear antigens to which 
patients have antibodies i  obviously of importance 
not only in furthering our understanding of the con- 
nective tissue diseases but also in enabling their spe- 
cific antibodies to be used with certainty as probes in 
investigations of RNA splicing mechanisms. Curiously, 
the analyses of Sm and RNP antigens carried out by 
various laboratories do not show a uniformly consis- 
tent pattern. In our opinion there are several major 
factors which can influence the composition of 
RNA-protein complexes with which anti-Sm/RNP 
antibodies will react. 
5.1. Detection of antigens 
Several authors have used antigens which have been 
radioactively labelled in vivo, whereas others use 
unlabelled extracts (table 1). Thus, the use of labelled 
material may bias subsequent analyses towards 
detecting proteins and RNA with a relatively rapid 
turnover or proteins of a specific amino acid compo- 
sition. Could the detection of antigen protein by 
fluorography or staining explain the differences in 
relative abundance of the low Mr protein species pre- 
viously referred to? 
The prevalence of anti-Sm and anti-RNP antibodies 
in human disease has been documented elsewhere, 
e.g., antibody titre and specificity may be determined 
by techniques such as haemagglutination, complement 
fixation, counterimmunoelectrophoresis and double 
diffusion in agar(ose) [26]. Such autoimmune sera are 
known to contain antibodies of the IgG class which 
are precipitating in nature. However, most investiga- 
tors have used a limited number of sera obtained 
from quite separate, though clinically defined, groups 
of patients. There appears to have been little, if any, 
exchange of sera amongst laboratories for comparative 
purposes and techniques such as those described above 
show immunological identities that are probably due 
to properties of a gross nature compared to those seen 
using analysis of molecular constituents. 
It is possible to conclude, therefore, that antibodies 
from individuals in the same disease class may recog- 
nise antigenic sites carried by different groups of pro- 
teins and RNAs. Indications of this nature have been 
shown in recent claims that individual small RNA 
species or protein components obtained from purified 
antigens can react with anti-Sm/RNP antibodies 
(table 2). These studies how little consistency in the 
type of protein detected as autoantigens and they 
suggest that other factors are at play. Admittedly the 
use of hybridoma techniques can allow selection of 
subsets of antibody, but the fact that apparently con- 
flicting results can also be obtained with human auto- 
immune sera requires explanation. 
In their comprehensive survey Steitz’s laboratory 
(see [7,10]) found that a wide range of RNAs are in 
fact precipitable by individual sera. In addition, White 
and Hoch [23], using a ‘blotting’ technique, have 
observed significant differences in the proteins reacting 
with anti-Sm/RNP sera that are both of a species (for 
antigen) and patient (for antibody) origin. The striking 
differences found in the proteins associated with HeLa 
RNP antigen by two laboratories [4,12] have also 
been interpreted as indicating variations in the detailed 
specificity of anti-RNP sera from different patients 
[ 121. Hence some degree of antibody specificity for 
Sm and RNP at a molecular level cannot be dismissed, 
even in sera from patients with the same clinically 
defined condition. 
We have based our identification of the two anti- 
gens on immunoprecipitation, i.e., the criteria used in 
the original designation ofthe antigens [2]. Techniques 
which employ other means of immunological identi- 
fication, e.g., ‘protein-blotting’ [22,23], immuno- 
affinity chromatography [ 15 -2 l] or precipitation of 
immune complexes with Staphylococcus protein A 
[3,13] will detect or utilise non-precipitating aswell 
as precipitating antibodies. Should the detailed spe- 
cificities of these 2 categories of antibody differ then 
different methods of detection could play an impor- 
tant role in the analysis given in tables 1 and 2. It is 
important o note that no comprehensive investigation 
has been carried out of such features of antibodies 
found in these autoimmune diseases. 
5.2. Cell and tissue sources 
Sm and RNP are present in the nuclei of numerous 
(but not all) eukaryotic species [2,4,7,10]. The cell 
types used in the analyses given in table 1 consist of 
3 main groups: 
(i) Rapidly dividing tumour cells such as HeLa [4]; 
(ii) Virus-producing Friend erythroleukaemia mouse 
143 
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cells undergoing erythropoietic differentiation 
[131; 
(iii) Differentiated tissues undergoing significant 
(liver, [20]) or little (thymus, [9,18,19]) RNA 
synthesis. 
It may be significant, therefore, that extreme varia- 
tions in antigen composition are found in HeLa and 
thymus cells. 
5.3. Extraction and isolation of antigens 
Most studies have involved nuclei from fresh tissue/ 
cells but in the case of rabbit thymus several aborato- 
ries [ 18,19,21] have used commercially available, 
acetone-dried tissue powders as their source of antigen. 
As no comparative studies have been carried out it is 
unknown how the composition of antigens from this 
source differs from those derived by the more conven- 
tional preparative procedure, viz. as soluble extracts 
obtained by sonication [4] or homogenisation [9] 
of nuclei in saline solution. The latter procedure yields 
Sm and RNPantigenslargely as forms which sediment 
at 10 S [9], but, as will be described later, both can 
be obtained either exclusively [ 13,201 or in part [4] 
associated with nuclear material of an S-value >30. 
Three investigations [4,13,20] mentioned in table 1 
would appear to have involved such large forms of the 
antigens. Hence, it is conceivable that in the immuno- 
precipitates obtained the antigenic determinants were 
part of a complex containing RNA and protein mole- 
cules not seen in the purely 10 S forms of the antigens. 
Such a proposal is supported by the differences in the 
composition of Friend cell Sm and RNP antigens when 
they are studied as part of either >30 S [ 131 or <30 S 
complexes [lo]. 
The means of isolation of the antigens has varied 
from immunoaffinity chromatography [ 15-2 1 ] to 
purely analytical procedures such as the rapid forma- 
tion of immune complexes from crude nuclear extracts 
[3]. The use of chaotropic salts in the former and the 
potential for non-specific binding of molecules in the 
latter approach (see controls in [ 121 and discussion in 
[ 131) illustrate the range of conditions to which these 
antigens are exposed during their isolation. 
5.4. Nuclear sources of protein associated with Sm/RNP 
Although snRNAs have been highly conserved in 
sequence, the proteins accompanying them in nuclear 
particles could be cell specific. Alternatively, these 
variations could indicate either non-specific binding 
components or some structural nuclear proteins which 
144 
are complexed with the antigenic sites in a cell-specific 
manner. Such possibilities are indicated by the fact 
that treatment of a nuclear extract with trypsin still 
yields a precipitable Sm antigen which has lost the 
12 000 Mr protein and some of the 10 000 Mr group 
[9]. Similar results have been found in [21] showing 
that certain of the lower Mr group of proteins do not 
appear to be essential for the precipitable antigenic 
structure. 
Apart from the results in [ 121 it is obvious that 
the group of proteins associated with most prepara- 
tions of these antigens bear little resemblance to 
those of isolated snRNP particles, since in general the 
latter have M, > 40 000 [27,28]. It should be noted 
that Brunel et al. [29] did obtain a preparation of 
snRNPs, the proteins of which were exclusively 
between 10 000-14 OOOM,, but no reaction occurred 
when such snRNPs were exposed to anti-RNP anti- 
bodies. 
5.5. Nuclear sources of RNA associated with Sm/RNP 
The presence of unidentified, particularly very 
small, RNA species in immunoprecipitates is suggestive 
that these components are degradation products of 
larger molecules. Admittedly, little attempt has been 
made to inhibit ribonucleases in many of these studies, 
but when this is done [9,21] very small RNAs are still 
observed. Even so, the action of nucleases cannot be 
ignored since Takano et al. [ 191 indicated that the 
very small RNA seen associated with thymus RNP is 
similar to U,,-snRNA and furthermore, Epstein et al. 
[30] have reported that after cleavage of its Ur at 
some 5 sites with T,-RNase, Sm antigen is still precip- 
itable by anti-Sm antibodies. Thus, the snRNA does 
not have to be intact for immunological recognition. 
From these compositions Sm and RNP antigens 
are not necessarily representative of the nuclear snRNP 
particles of each cell type. They could, for example, 
be a subset resulting from cellular degradation pro- 
cesses. Alternatively other nuclear sources of RNA 
should not be dismissed. Nuclear RNP particles, other 
than snRNPs, have been described which sediment 
between 5-20 S, e.g., HnRNP degradation products 
[3 l] which include a 15 S particle containing the 
3’-poly(A) tract [32] or the 7 S particle containing 
processed HnRNA as proposed in [33]. It is conceiv- 
able that all or any of these sources could contribute 
to a nuclear pool of ‘core’ RNP particles which possess 
common antigenic determinant sites recognisable by 
anti-Sm/RNP antibodies. The significant quantitative 
Volume 141, number 2 FEBS LETTERS May 1982 
differences in the nuclear content of snRNAs amongst 
rat tissue [34] and in Friend cells at different stages 
of growth and differentiation [35] suggest hat rela- 
tive contributions from such sources could be tissue 
or growth dependent, resulting in different patterns 
of small RNAs precipitating with the autoimmune 
antibodies. The presence of sn- and unidentified RNAs 
in antigens precipitated from HeLa and thymus cells 
respectively support the existence of such effects. 
6. Antigens as single protein or RNA molecules 
The data given in table 2 suggest hat of the isolated 
components of purified antigens with which anti-Sm/ 
RNP antibodies react, protein, rather than RNA, car- 
ries the antigenic determinants. It has been concluded 
that these sites are the same as those involved in the 
forms of the antigens described in table 2 and, if so, 
these results contrast with some of the established 
properties of Sm and RNP. For example, both Sm 
and RNP can be found to be sensitive to protease and 
ribonuclease [9,36], indicating that the antigenic 
determinant sites contain protein and RNA. An alter- 
native view has now been put that the RNA is simply 
acting as a carrier for the protein determinant [23]. 
The wide range of RNA molecules found associated 
with the antigens (table 1) would thus mean that the 
antigenic protein species were bound to different 
RNAs in different cell types. However, the complexity 
of the situation is shown by both direct [ 11,231 and 
indirect comparative studies (table 2) in which the 
antigenic proteins are found to be species and sera 
specific. 
It has to be stressed that there is no evidence to 
indicate that the antibodies utilised in analysing RNA- 
protein complexes (table 1) are the same as those 
used to detect antigenic determinants on separated 
protein or RNA molecules (table 2). Equally, we do 
not know at present if the antigenic determinants 
seen on individual RNAs and proteins (table 2) are 
detectable in the complexes used in table 1. These 
matters await clarification. 
7. Subnuclear location of antigens in vivo 
Although there is considerable evidence that Sm 
and RNP antigens are of nuclear origin [2], their true 
subnuclear location has only been considered recently. 
The majority of studies have been carried out using 
soluble preparations of these components but as 
described in [9] a significant proportion of Sm and 
RNP remains in the nuclear residue after extraction 
with saline. Admittedly conditions of extraction 
(time, volume, ionic strength) can be devised which 
will extract virtually all of the antigens from nuclei, 
but their ease of partial solubility has precluded 
attempts to identify the subnuclear sites to which 
they bind [9]. 
Independent evidence has recently accumulated 
suggesting that the subnuclear location of the antigens 
in vivo may be large HnRNP particles (up to 200 S) 
[ 13,201. Such forms of RNP particles are released 
from nuclear preparations by sonication in either 
0.01 M or 0.14 M NaCl [13,20], i.e., the effect does 
not appear to follow directly the salt-dependent 
distribution of snRNAs between 10 S and HnRNP 
particles [37]. Further manipulation (e.g., incubation 
at 37’C) of these high S-value forms of the antigens 
results in their conversion to a form sedimenting at 
<20 S, i.e., similar to that obtained by simple extrac- 
tion of nuclei with saline (T. Y. J., unpublished). 
In view of the snRNA content of antigens extracted 
from some cell types it is relevant that snRNAs have 
been found tightly bound to HnRNP (see [38]). 
Secondly, the current view that HnRNPs are themselves 
bound to the nuclear matrix [39] means a possible 
association of antigen with components of at least 2 
nuclear structures. Assuming that the sonication pro- 
cedure involved retains structures found in vivo, the 
above experiments support the proposal that Sm and 
RNP determinants are integral components of the 
HnRNPs. Hence, the release of antigen from nuclei 
may be the result of dissociation from or degradation 
of HnRNP complexes during extraction. Such a model 
would also suggest hat the cell type and the method 
of preparation would determine the particular (pro- 
tein) antigenic sites, their range of associated non- 
antigenic RNA and protein molecules and thus 
whether the determinants were on single or multiple 
antigen complexes. The differences in composition of 
Friend cell Sm and RNP found using complexes sedi- 
menting at >30 S [13] or <30 S [lo] confirm the 
importance of preparative procedures in these analyses. 
Furthermore, the following forms of Sm and RNP 
appear to have been used in the studies listed in 
table 1, Sm and RNP >30 S [ 13,201, Sm associated 
with both 30 S HnRNP and 10 S particles [4] and Sm 
and RNP solely as 10 S particles [9]. In view of the 
145 
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other variables discussed it is perhaps not surprising 
to find that these 4 laboratories have produced the 
range of analyses described in table 1. 
8. Conclusions 
Our view is that Sm and RNP are antigenic deter- 
minants on large HnRNP particle complexes and that 
these determinants may be released either singly or 
together associated with other proteins and RNA 
molecules. Variations in the reports of the composi- 
tion of Sm and RNP antigens can then be attributed 
to combinations of the aspects reviewed above, e.g., 
cell type, extraction conditions and method of detec- 
tion. 
Several important issues are unresolved. These 
include: 
sites found on isolated proteins to those detected 
in RNA-protein complexes; 
(1) The correspondence or otherwise of the antigenic 
(2) The factors behind the presence of different 
types of RNA associated with antigens precipi- 
tated from different cells. 
The data reviewed above suggest hat we are far 
from ascertaining the function or even the exact com- 
position of the Sm and RNP antigens. We propose, 
therefore, that the evidence in this review suggests 
that caution should be exerted in experiments in which 
these autoantibodies are used in investigations of RNA 
splicing mechanisms. Lewin [40] has already suggested 
that appropriate experimental controls are required 
in such investigations and we would recommend that 
for any type of application characterisation of the 
antigens is a necessity for each cell type and serum 
to be used. The recent work of Lenk et al. [ 121 sup- 
ports such an approach. 
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